Embedded CRISPRi Enhances Gene‐Silencing Efficiency in Drosophila
Advanced Science · 2026-06 · 13 (31)
DOI: 10.1002/advs.202515849 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 20.03.2026. Verfasst von Pengchong Fu und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, Jiangsu Province, China. Hauptthemen laut MEDLINE: Drosophila melanogaster, CRISPR-Cas Systems, Gene Silencing, Amyotrophic Lateral Sclerosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, priority academic program development of jiangsu higher education institutions.
Abstract (Originalsprache)
CRISPR interference (CRISPRi), leveraging catalytically inactive Cas9 (dCas9), has transformed transcriptional silencing. However, its application in Drosophila melanogaster has been constrained by inconsistent efficiency and limited repression amplitude. Here, we present embedded CRISPR interference (emCRISPRi), an advanced gene‐silencing platform that integrates transcriptional repression domains (Mxi and TRD) into a structurally flexible region of dCas9. This design significantly enhances silencing efficiency, enabling robust repression of coding genes and cis‐regulatory elements, particularly at transcription start site (TSS)‐proximal regions. emCRISPRi demonstrates improved gene‐silencing activity compared to RNA interference (RNAi) at several tested loci and facilitates strong phenotypic rescue via unmodified cDNA. Its versatility is demonstrated through the dissection of Hippo pathway interactions and the mitigation of TDP‐43‐induced neurotoxicity in an amyotrophic lateral sclerosis (ALS) model. These findings position emCRISPRi as a transformative tool for functional genomics, enhancer studies, and disease modeling in Drosophila , with significant potential for cross‐species adaptation and therapeutic innovation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, Jiangsu Province, China.
- Gene Editing Center, School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
ORCID-Profile: Guanjun Gao
Förderung
- National Natural Science Foundation of China
- priority academic program development of jiangsu higher education institutions
Zitieren
APA
Fu, P., Zhang, X., Zhou, Y., Zheng, J., Sun, A., Zhuang, K., Bao, W., & Gao, G. (2026). Embedded CRISPRi Enhances Gene‐Silencing Efficiency in Drosophila. Advanced Science, 13(31). https://doi.org/10.1002/advs.202515849
Vancouver
Fu P, Zhang X, Zhou Y, Zheng J, Sun A, Zhuang K, et al. Embedded CRISPRi Enhances Gene‐Silencing Efficiency in Drosophila. Advanced Science. 2026;13(31). doi:10.1002/advs.202515849
BibTeX
@article{Fu2026,
author = {Fu, Pengchong and Zhang, Xuedi and Zhou, Ying and Zheng, Jie and Sun, Angyang and Zhuang, Kailong and Bao, Weiwei and Gao, Guanjun},
title = {Embedded CRISPRi Enhances Gene‐Silencing Efficiency in Drosophila},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {31},
doi = {10.1002/advs.202515849}
}
EUVIMED